Davita Inc vs Eos Energy Enterprises Inc — how do they compare? Davita Inc trades at $179.25 (market cap $11.29B), while Eos Energy Enterprises Inc trades at $2.52 (market cap $1.01B). The key difference: Davita Inc is far larger — about 11.2× Eos Energy Enterprises Inc's market cap, and Davita Inc is trading nearer its 52-week high, Eos Energy Enterprises Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Davita Inc for 114 Days and Eos Energy Enterprises Inc for 16 Days on average.
| DVA | EOSE | |
|---|---|---|
Market Cap | $11.29B | $1.01B |
Volume | 582,204 | 39,626,541 |
Sector | Health | Industrials |
52-Week High | $240.96 | $19.19 |
52-Week Low | $103.87 | $2.52 |
Typical Hold Time | 114 Days | 16 Days |
Enterprise Value | $24.01B | $1.34B |
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $177.02, up 0.14% with a bearish technical signal despite recent earnings beats. The stock shows strong fundamentals with a P/E of 15 and revenue growth from $13.64B in 2025 to projected $14.0B in 2026. Recent news highlights value-based care expansion with Humana and institutional buying by BlackRock. Technical indicators show resistance at $179 and support at $175, with RSI neutral at 59.72.
DVA presents a mixed outlook: analyst consensus targets $235.67 (33% upside) with 43% buy ratings, but technicals suggest near-term pressure. Key opportunities include consistent EPS beats and partnership growth, while risks involve rising debt-to-asset ratio (65.55% in 2025) and regulatory exposure. Net cash flow turned negative in 2025, requiring monitoring.
Eos Energy Enterprises (EOSE) trades at $2.765, down 10.81% on the day, reflecting a bearish technical trend. The company is in a high-growth phase, with revenue surging from $114 million in 2025 to $214 million in 2026, but it remains deeply unprofitable with a net income margin of -246.76%. Recent positive developments include a major partnership with Google and a $87 million Department of Energy loan advance to expand production capacity.
The outlook is a high-risk, high-reward proposition. Analyst consensus is a 'Buy' with a $7.10 price target, implying significant upside, but this is contingent on the company achieving profitability as it scales. Key risks include persistent cash burn, intense competition in energy storage, and execution challenges in ramping production.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →Eos Energy Enterprises provides long-duration energy storage solutions. Its signature zinc-based batteries are designed for utility-scale applications, helping to stabilize power grids and integrate renewable energy.
Read more on EOSE →